Cargando…

Low Expression of TSTD2 Serves as a Biomarker for Poor Prognosis in Kidney Renal Clear Cell Carcinoma

INTRODUCTION: Kidney renal clear cell carcinoma (KIRC) is a common cancer in people worldwide, and one of the main issues is developing suitable biomarkers. This study aims to investigate the expression of TSTD2 in KIRC and its impact on prognosis. METHODS: RNA sequencing data from TCGA and GTEx wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Gonglin, Sun, Kai, Ding, Guixin, Wu, Jitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126726/ https://www.ncbi.nlm.nih.gov/pubmed/37114071 http://dx.doi.org/10.2147/IJGM.S408854

Ejemplares similares

Promoter hypomethylation and overexpression of TSTD1 mediate poor treatment response in breast cancer
por: Ansar, Muhamad, et al.
Publicado: (2022)

Serum anti‑TSTD2 antibody as a biomarker for atherosclerosis‑induced ischemic stroke and chronic kidney disease
por: Kubota, Masaaki, et al.
Publicado: (2022)

SKA3 Serves as a Biomarker for Poor Prognosis in Kidney Renal Papillary Cell Carcinoma
por: Feng, Dechao, et al.
Publicado: (2021)

PIMREG is a prognostic biomarker involved in immune microenvironment of clear cell renal cell carcinoma and associated with the transition from G1 phase to S phase
por: Yao, Huibao, et al.
Publicado: (2023)

Wiskott-Aldrich syndrome gene as a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma
por: Ding, Guixin, et al.
Publicado: (2023)

OSM May Serve as a Biomarker of Poor Prognosis in Clear Cell Renal Cell Carcinoma and Promote Tumor Cell Invasion and Migration
por: Wei, Shuzhang, et al.
Publicado: (2023)

Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma
por: Wang, Qi, et al.
Publicado: (2022)

FSIP2 can serve as a predictive biomarker for Clear Cell Renal Cell Carcinoma prognosis
por: Zhang, Yixiao, et al.
Publicado: (2020)

Overexpressing IFITM family genes predict poor prognosis in kidney renal clear cell carcinoma
por: Xu, Ying, et al.
Publicado: (2021)

Long Noncoding RNA HOTTIP Serves as an Independent Predictive Biomarker for the Prognosis of Patients with Clear Cell Renal Cell Carcinoma
por: Liu, Zhanxin, et al.
Publicado: (2020)

Overexpressing PTTG family genes predict poor prognosis in kidney renal clear cell carcinoma
por: Gui, Yonghui, et al.
Publicado: (2021)

Downregulation of PPA2 expression correlates with poor prognosis of kidney renal clear cell carcinoma
por: Zhu, Wenbiao, et al.
Publicado: (2021)

The Efficacy of Cyclooxygenase-2 Inhibitors for the Male Treatment of Lower Urinary Tract Symptoms: A Systematic Review and Meta-Analysis
por: Tang, Gonglin, et al.
Publicado: (2023)

Rab25 expression predicts poor prognosis in clear cell renal cell carcinoma
por: LIU, LUNZHI, et al.
Publicado: (2014)

BRCA1/2 Serves as a Biomarker for Poor Prognosis in Breast Carcinoma
por: Jin, Tong Yi, et al.
Publicado: (2022)

Integrative Analyses Reveal Tstd1 as a Potential Modulator of HDL Cholesterol and Mitochondrial Function in Mice
por: Zheng, Adi, et al.
Publicado: (2021)

Elevated PTTG1 predicts poor prognosis in kidney renal clear cell carcinoma and correlates with immunity
por: Zhang, Xinyu, et al.
Publicado: (2023)

Expression signature of six‐snoRNA serves as novel non‐invasive biomarker for diagnosis and prognosis prediction of renal clear cell carcinoma
por: Zhao, Yanyun, et al.
Publicado: (2020)

The CSRNP Gene Family Serves as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma
por: Zhang, Huaru, et al.
Publicado: (2021)

Glycolysis-Related Genes Serve as Potential Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma
por: Zhang, Yan, et al.
Publicado: (2021)

IQGAP3 May Serve as a Promising Biomarker in Clear Cell Renal Cell Carcinoma
por: Meng, Quan, et al.
Publicado: (2021)

HMGCS2 serves as a potential biomarker for inhibition of renal clear cell carcinoma growth
por: Mao, Huajie, et al.
Publicado: (2023)

Homologous recombination deficiency serves as a prognostic biomarker in clear cell renal cell carcinoma
por: He, Liping, et al.
Publicado: (2023)

Transketolase Serves as a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma
por: Niu, Cong, et al.
Publicado: (2022)

Low Expression of Mucin-4 Predicts Poor Prognosis in Patients With Clear-Cell Renal Cell Carcinoma
por: Fu, Hangcheng, et al.
Publicado: (2016)

Microenvironment-related gene TNFSF13B predicts poor prognosis in kidney renal clear cell carcinoma
por: Jiang, Mingzhe, et al.
Publicado: (2020)

Downregulation of enhancer RNA EMX2OS is associated with poor prognosis in kidney renal clear cell carcinoma
por: Jiang, Huiming, et al.
Publicado: (2020)

A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma
por: Xiao, Yongshuang, et al.
Publicado: (2022)

Pseudogene HSPA7 is a poor prognostic biomarker in Kidney Renal Clear Cell Carcinoma (KIRC) and correlated with immune infiltrates
por: Ding, Chunjin, et al.
Publicado: (2021)

High Hepcidin expression predicts poor prognosis in patients with clear cell renal cell carcinoma
por: Tang, Yuting, et al.
Publicado: (2022)

Higher TYROBP and lower SOX6 as predictive biomarkers for poor prognosis of clear cell renal cell carcinoma: A pilot study
por: Lv, Xian-Qiang, et al.
Publicado: (2022)

ASNS can predict the poor prognosis of clear cell renal cell carcinoma
por: Gan, Xinqiang, et al.
Publicado: (2022)

Identification of prognosis‐related alternative splicing events in kidney renal clear cell carcinoma
por: Zuo, Yongdi, et al.
Publicado: (2019)

Toll-Like Receptors Serve as Biomarkers for Early Diagnosis and Prognosis Assessment of Kidney Renal Clear Cell Carcinoma by Influencing the Immune Microenvironment: Comprehensive Bioinformatics Analysis Combined With Experimental Validation
por: Zou, Xiong, et al.
Publicado: (2022)

FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma
por: Yu, Yilin, et al.
Publicado: (2021)

Low DAPK1 expression correlates with poor prognosis and sunitinib resistance in clear cell renal cell carcinoma
por: Song, Zhengshuai, et al.
Publicado: (2020)

Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma
por: Qiu, Jiechuan, et al.
Publicado: (2023)

Reduced GRAMD1C expression correlates to poor prognosis and immune infiltrates in kidney renal clear cell carcinoma
por: Hao, Haiyan, et al.
Publicado: (2019)

Ferroptosis‐related gene CHAC1 is a valid indicator for the poor prognosis of kidney renal clear cell carcinoma
por: Li, Deng, et al.
Publicado: (2021)

TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma
por: Gao, Wen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2na5do1hc8ipico3qdnk0gpgpo